Digestive enzyme expression in the large intestine of children with short bowel syndrome in a late stage of adaptation FASEB J. 2020 Mar;34(3):3983-3995. doi: 10.1096/fj.201901758RR. Epub 2020 Jan 19. Jan de Laffolie 1, Diana Sheridan 2, Konrad Reinshagen 3, Lucas Wessel 4, Christian Zimmermann 1, Sebastian Stricker 1, Markus M Lerch 5, Markus Weigel 6 7, Torsten Hain 6 7, Eugen Domann 6 7, Silvia Rudloff 1, Buford L Nichols 8, Hassan Y Naim 9, Klaus-Peter Zimmer 1 |
Author information
Abstract Background and aims: Intestinal adaptation in short bowel syndrome (SBS) includes morphologic processes and functional mechanisms. This study investigated whether digestive enzyme expression in the duodenum and colon is upregulated in SBS patients. Method: Sucrase-isomaltase (SI), lactase-phlorizin hydrolase (LPH), and neutral Aminopeptidase N (ApN) were analyzed in duodenal and colonic biopsies from nine SBS patients in a late stage of adaptation as well as healthy and disease controls by immunoelectron microscopy (IEM), Western blots, and enzyme activities. Furthermore, proliferation rates and intestinal microbiota were analyzed in the mucosal specimen. Results: We found significantly increased amounts of SI, LPH, and ApN in colonocytes in most SBS patients with large variation and strongest effect for SI and ApN. Digestive enzyme expression was only partially elevated in duodenal enterocytes due to a low proliferation level measured by Ki-67 staining. Microbiome analysis revealed high amounts of Lactobacillus resp. low amounts of Proteobacteria in SBS patients with preservation of colon and ileocecal valve. Colonic expression was associated with a better clinical course in single cases. Conclusion: In SBS patients disaccharidases and peptidases can be upregulated in the colon. Stimulation of this colonic intestinalization process by drugs, nutrients, and pre- or probiotics might offer better therapeutic approaches. |
© Copyright 2013-2025 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.